Nimrod Dar1,2, Shani Pillar3,4, Asaf Friehmann3,4, Avner Belkin3,4, Shay Ofir3,4. 1. Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. Nimrod.dar@gmail.com. 2. Department of Ophthalmology, Meir Medical Center, Kfar Saba, Israel. Nimrod.dar@gmail.com. 3. Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. 4. Department of Ophthalmology, Meir Medical Center, Kfar Saba, Israel.
Abstract
PURPOSE: To compare the clinical features, visual outcomes and causative organisms between endophthalmitis secondary to cataract surgery or to intravitreal injections (IVI). SETTING: Meir Medical Center, Kfar Saba, Israel. DESIGN: Retrospective, non-randomized comparative chart review. METHODS: Medical records of patients with proven or suspected endophthalmitis admitted to the Ophthalmology Department at Meir Medical Center 2/2002-2/2017 were reviewed. Clinical characteristics including presenting and final visual acuity (VA) outcomes, causative organisms and time to admission were assessed. RESULTS: Among 84 patients in our study, 35 had preceding cataract surgery and 12 had preceding IVI. The post-cataract group showed a significant improvement in VA following treatment with a presenting and final VA (logMar ± SD) of (1.80 ± 0.54 and 1.39 ± 0.65, P < 0.01) as opposed to the post-IVI group (1.72 ± 0.26 and 1.81 ± 0.32, P = 0.692), while most patients in the cataract group exhibited some degree of VA recovery (70.96%). Patients undergoing cataract surgery were divided into two separate groups; those who underwent cataract surgery in a private center and those operated at a public center. Patients undergoing surgery at a private medical center showed improvement in VA outcomes following treatment (1.80 ± 0.57 and 1.13 ± 0.66, P < 0.01) as opposed to those operated on at our public medical center. CONCLUSIONS: Overall, patients with endophthalmitis following cataract surgery had better visual outcomes and were more likely to show a VA improvement following treatment when compared with endophthalmitis following IVI. Final VA outcomes of patients with endophthalmitis after cataract surgery performed in a private center were better than those operated on and treated in a public medical center.
PURPOSE: To compare the clinical features, visual outcomes and causative organisms between endophthalmitis secondary to cataract surgery or to intravitreal injections (IVI). SETTING: Meir Medical Center, Kfar Saba, Israel. DESIGN: Retrospective, non-randomized comparative chart review. METHODS: Medical records of patients with proven or suspected endophthalmitis admitted to the Ophthalmology Department at Meir Medical Center 2/2002-2/2017 were reviewed. Clinical characteristics including presenting and final visual acuity (VA) outcomes, causative organisms and time to admission were assessed. RESULTS: Among 84 patients in our study, 35 had preceding cataract surgery and 12 had preceding IVI. The post-cataract group showed a significant improvement in VA following treatment with a presenting and final VA (logMar ± SD) of (1.80 ± 0.54 and 1.39 ± 0.65, P < 0.01) as opposed to the post-IVI group (1.72 ± 0.26 and 1.81 ± 0.32, P = 0.692), while most patients in the cataract group exhibited some degree of VA recovery (70.96%). Patients undergoing cataract surgery were divided into two separate groups; those who underwent cataract surgery in a private center and those operated at a public center. Patients undergoing surgery at a private medical center showed improvement in VA outcomes following treatment (1.80 ± 0.57 and 1.13 ± 0.66, P < 0.01) as opposed to those operated on at our public medical center. CONCLUSIONS: Overall, patients with endophthalmitis following cataract surgery had better visual outcomes and were more likely to show a VA improvement following treatment when compared with endophthalmitis following IVI. Final VA outcomes of patients with endophthalmitis after cataract surgery performed in a private center were better than those operated on and treated in a public medical center.
Authors: Peter Barry; David V Seal; George Gettinby; Fiona Lees; Magnus Peterson; Crawford W Revie Journal: J Cataract Refract Surg Date: 2006-03 Impact factor: 3.351
Authors: Philip Storey; Michael Dollin; John Pitcher; Sahitya Reddy; Joseph Vojtko; James Vander; Jason Hsu; Sunir J Garg Journal: Ophthalmology Date: 2013-10-18 Impact factor: 12.079
Authors: Ana Maria Cunha; Maria Manuel Iglésias; Amândio Rocha-Sousa; Fernando Falcão-Reis; Manuel Falcão Journal: J Ophthalmol Date: 2021-09-20 Impact factor: 1.909